iShares Trust - iShares U.S. Healthcare ETF Valuation
Is IYH undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
1/6Valuation Score 1/6
Below Fair Value
Significantly Below Fair Value
Price-To-Book vs Peers
Price-To-Book vs Industry
Price-To-Book vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of IYH when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: IYH ($58.61) is trading above our estimate of fair value ($17.74)
Significantly Below Fair Value: IYH is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for IYH?
Other financial metrics that can be useful for relative valuation.
| What is IYH's n/a Ratio? | |
|---|---|
| n/a | 0x |
| n/a | n/a |
| Market Cap | US$3.25b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 62.7x |
| Enterprise Value/EBITDA | n/a |
| PEG Ratio | n/a |
Price to Book Ratio vs Peers
How does IYH's PB Ratio compare to its peers?
| Company | Forward PB | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | n/a | ||
IYH iShares Trust - iShares U.S. Healthcare ETF | 1.1x | n/a | US$3.3b |
Price-To-Book vs Peers: Insufficient data to calculate IYH's Price-To-Book Ratio vs. peers for valuation analysis.
Price to Earnings Ratio vs Industry
How does IYH's PE Ratio compare vs other companies in the US Capital Markets Industry?
Price-To-Book vs Industry: IYH is good value based on its Price-To-Book Ratio (1.1x) compared to the US Capital Markets industry average (1.4x).
Price to Book Ratio vs Fair Ratio
What is IYH's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PB Ratio | 1.1x |
| Fair PB Ratio | n/a |
Price-To-Book vs Fair Ratio: Insufficient data to calculate IYH's Price-To-Book Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.